Pharco SA logo

PHAR - Pharco SA Share Price

€0.35 0.0  0.0%

Last Trade - 05/03/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £528k
Position in Universe th / 846
Bullish
Bearish
Unlock PHAR Revenue
Momentum
Relative Strength (%)
1m -2.26%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2002 2003 2004 2005 2006 2007 2008E 2009E CAGR / Avg
0.000 0.000 1.43 1.69 0.033 0.61 -24.9%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2007, PharcoSA's gross revenue increased from EUR33K to EUR608K. Netloss for the period decreased 90% to EUR48K. Gross revenuereflects better performance across the Company's sales andservices. Lower net loss for the period reflectssignificant increase in operating margins as well decreasedsocial charges and other salaries related expenses as wellas higher exceptional income.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PHAR Revenue Unlock PHAR Revenue

Net Income

PHAR Net Income Unlock PHAR Revenue

Normalised EPS

PHAR Normalised EPS Unlock PHAR Revenue

PE Ratio Range

PHAR PE Ratio Range Unlock PHAR Revenue

Dividend Yield Range

PHAR Dividend Yield Range Unlock PHAR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PHAR EPS Forecasts Unlock PHAR Revenue
Profile Summary

Pharco SA is a Belgium-based pharmaceutical company that is active in phototherapy, slimming, nutritherapy and cosmetics. Its phototherapy activities consist of manufacturing and selling natural remedies for the treatment of common ailments. The slimming activities include online dietary advices and the manufacturing of nutritional supplements. The Company’s nutritherapy operations provide such products as supplements for well-being and the treatment of stress, menopause and common cold. Pharco is also engaged in the manufacturing of cosmetics, including breast lifting cream and products for the treatment of cellulite.

Directors
Last Annual December 31st, 2007
Last Interim January 1st, 1970
Incorporated December 26, 2003
Public Since May 30, 2006
No. of Shareholders: n/a
No. of Employees: 11
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Euronext - Brussels
Shares in Issue 1,550,867
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PHAR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PHAR
Upcoming Events for PHAR
Frequently Asked Questions for Pharco SA
What is the Pharco SA share price?

As of 05/03/19, shares in Pharco SA are trading at €0.35, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Pharco SA share price performed this year?

Shares in Pharco SA are currently trading at €0.35 and the price has moved by -30% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Pharco SA price has moved by -33.1% over the past year.

What are the analyst and broker recommendations for Pharco SA?

There are no analysts currently covering Pharco SA.

When will Pharco SA next release its financial results?

It is not known when Pharco SA will next release financial results.

What is the Pharco SA dividend yield?

Pharco SA does not currently pay a dividend.

Does Pharco SA pay a dividend?

Pharco SA does not currently pay a dividend.

When does Pharco SA next pay dividends?

Pharco SA does not currently pay a dividend.

How do I buy Pharco SA shares?

To buy shares in Pharco SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Pharco SA?

Shares in Pharco SA are currently trading at €0.35, giving the company a market capitalisation of £n/a.

Where are Pharco SA shares listed? Where are Pharco SA shares listed?

Here are the trading details for Pharco SA:

Country of listing: Belgium
Exchange: BRU
Ticker Symbol: PHAR
What kind of share is Pharco SA?

We were not able to load our ranking data for Pharco SA

Is there a Pharco SA share price forecast 2021?

We were not able to load any forecast data for Pharco SA.

How can I tell whether the Pharco SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharco SA. Over the past six months, the relative strength of its shares against the market has been -10.72%. At the current price of €0.35, shares in Pharco SA are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Pharco SA PE Ratio?

We were not able to find PE ratio data for Pharco SA.

Who are the key directors of Pharco SA?

We were unable to find the directors for Pharco SA.

Who are the major shareholders of Pharco SA?

Here are the top five shareholders of Pharco SA based on the size of their shareholding:

Similar to PHAR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.